awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q36499068-41307CDA-967C-4620-943A-999CD4B698B9
Q36499068-41307CDA-967C-4620-943A-999CD4B698B9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36499068-41307CDA-967C-4620-943A-999CD4B698B9
Stage IV EGFR Mutation-Negative and ALK Mutation-Negative Lung Adenocarcinoma: Long-Term Survival is Possible.
P2860
Q36499068-41307CDA-967C-4620-943A-999CD4B698B9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36499068-41307CDA-967C-4620-943A-999CD4B698B9
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b03eb1a25500a5ffe4f0b0f857aa9bc2fd972634
P2860
Phase II trial of pemetrexed plus bevacizumab for second-line therapy of patients with advanced non-small-cell lung cancer: NCCTG and SWOG study N0426.